Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 64 (HNRNPA1P64)

Target
HNRNPA1P64
Molecular classification
Other (processed pseudogene)
01

Overview

HNRNPA1P64 is a human pseudogene annotated as "heterogeneous nuclear ribonucleoprotein A1 pseudogene 64."[1][2][3] Pseudogenes are DNA sequences that resemble functional genes but have accumulated mutations that prevent them from encoding a functional protein[6]. HNRNPA1P64 is derived from the gene HNRNPA1, which is part of the heterogeneous nuclear ribonucleoprotein (hnRNP) family—RNA-binding proteins involved in RNA processing and gene expression regulation[5]. However, HNRNPA1P64 itself does not produce a functional protein or participate directly in these biological activities. Most pseudogenes, including HNRNPA1P64, are not actively transcribed or translated, although some pseudogenes in the genome may act via RNA-mediated regulatory mechanisms (e.g., as competitive endogenous RNAs or small interfering RNAs in rare cases)[6]. There is currently no evidence that HNRNPA1P64 functions in such a capacity. HNRNPA1P64 is a processed pseudogene derived from HNRNPA1, not a functional protein, receptor, or therapeutic target, and has no established role in disease, no known drug interactions, and no direct biological function[1][2][3][6].

Other names
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 64HNRNPA1P64
02

Biological functions

Other (no known direct biological functions; by definition, processed pseudogenes usually lack protein-coding capacity and function)
03

Disease associations

Other (no established roles in disease; no evidence for direct involvement in cancer, inflammation, neurodegenerative disease, or other pathologies[6])

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 64 (HNRNPA1P64).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 64 (HNRNPA1P64).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call